5-HT1A and β-adrenergic receptors regulate proliferation of rat blood lymphocytes

NeuroImmunoModulation

Volumn 11, Issue 5, 2004, Pages 307-315

  Sempere, Telésfora ^a   Urbina, Mary ^a   Lima, Lucimey ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Lymphocytes; Mitogens; Noradrenaline; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUSPIRONE; CD3 ANTIGEN; CLOMIPRAMINE; CONCANAVALIN A; DIATRIZOATE; FENCLONINE; FICOLL; IMIPRAMINE; ISOPRENALINE; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NORADRENALIN; PLASTIC; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; ZIMELDINE; 5 HYDROXYINDOLEACETIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBODY; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SEROTONIN BLOOD LEVEL; ANIMAL; BLOOD; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIBODIES; ANTIGENS, CD3; CELL DIVISION; CELLS, CULTURED; CONCANAVALIN A; FENCLONINE; HYDROXYINDOLEACETIC ACID; ISOPROTERENOL; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; NEUROIMMUNOMODULATION; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, BETA; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYMPATHOMIMETICS;

EID: 4444281971     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079411     Document Type: Article

References (55)

1. Qiu Y, Peng Y, Wang J: Immunoregulatory role of neurotransmitters. Adv Neuroimmunol 1996;6:223-231.
2. Solomon GF: Psychoneuroimmunology: Interactions between central nervous system and immune system. J Neurosci Res 1987;18:1-9.
3. Devoino L, Idova G, Alperina E, Cheido M: Brain neuromediator systems in the immune response control: Pharmacological analysis of pre- and postsynaptic mechanisms. Brain Res 1994;633:267-274.
4. Mossner R, Lesch KP: Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 1998;12:249-271.
5. Fecho K, Dykstra L, Lysle DT: Evidence for β-adrenergic receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 1993;265:1079-1087.
6. Nelson C, Dykstra L, Lyse D: Morphine's immunologic and analgesic effects. Comparison of time course. Adv Exp Med Biol 1998;437:169-175.
7. Benschop RJ, Oostveen FG, Heijnen CJ, Ballieux RE: Beta-2-adrenergic stimulation causes detachment of natural killer cells from cultured endothelium. Eur J Immunol 1993;23:3242-3247.
8. Carlson SL, Trauth K, Brooks WH, Roszman T: Enhancement of β-adrenergic-induced cAMP accumulation in activated T-cells. J Cell Physiol 1994;161:39-48.
9. Heo Y, Lee WT, Lawrence DA: Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 1998;43:172-185.
10. Katakami Y, Nakao Y, Koizumi T, Katakami N, Ogawa R, Fujita T: Regulation of tumour necrosis factor production by mouse peritoneal macrophages: The role of cellular cyclic AMP. Immunology 1998;69:719-724.
11. Ivashkiv L, Ayres A, Glimcher L: Inhibition of IFN-γ induction of class II MHC genes by cAMP and prostaglandins. Immunopharmacology 1994;27:67-77.
12. 2-adrenoceptor subtype. Am J Respir Cell Mol Biol 1998;19:400-407.
13. Siegel M, Zhang D, Ray D, Ray J: Activation of interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLEO elements. J Biol Chem 1995;270:24548-24555.
14. Zhang Y, Lin J, Vilcek J: Synthesis of interleukin-6 in human fibroblasts is triggered by an increase in cyclic AMP. J Biol Chem 1994;263:6177-6182.
15. Wingett DG, Forcier K, Nielson CP: Regulation of CD40L expression by cyclic AMP: Contrasting proinflammatory and inhibitory actions. Cell Immunol 1999;192:203-212.
16. 2-adrenergic receptor by Th1 and Th2 clones. J Immunol 1997;158:4200-4210.
17. Khom A, Sanders VM: Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol 1999;162:5299-5308.
18. Fuchs BA, Campbell KS, Munson AE: Norepinephrine and serotonin content of the murine spleen: Its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol 1988;117:339-351.
19. 2 serotonergic receptor antagonists. J Immunol 1986;137:733-741.
20. 1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand J Immunol 1993;37:7-18.
21. Bonnet M, Lespinats G, Burtin C: Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogenic cells. Cell Immunol 1984;83:280-291.
22. Khan I, Malla B, Wattal S, Agarwal S: Effect of serotonin on T lymphocyte proliferation in vitro in healthy individuals. Int Arch Allergy Appl Immunol 1986;81:378-380.
23. Young MRI, Kut JL, Coogan MP, Wright MA, Young ME, Matthews JM: Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993;80:395-400.
24. Stefulj J, Cicin-Sain L, Schauenstein K, Jernej B: Serotonin and immune response: Effect of the amine on in vitro proliferation of rat lymphocytes. Neuroimmunomodulation 2001;9:103-108.
25. Stefulj J, Jakopec S, Osmak M, Jernej B: Serotonin and apoptosis: Studies on rat lymphocytes. Neuroimmunomodulation 2002;10:132-133.
26. Kut J, Young R, Crayton J, Wright M, Young M: Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol Immunotoxicol 1992;14:783-796.
27. Aune T, Kelley KA, Ranges GE, Bombara MJ: Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol 1990;145:1826-1831.
28. 1A receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 1993;151:1175-1183.
29. 3H]-hydroxy-2- (di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization. J Neuroimmunol 2003;138:8-16.
30. Choquet D, Korn H: Dual effects of serotonin on a voltage-gated conductance in lymphocytes. Proc Natl Acad Sci USA 1988;85:4557-4561.
31. 1A receptors. Cell Immunol 1995;163:1-9.
32. Ferrière F, Khan N, Meynel J, Dechaux P: Characterization of serotonin transport mechanisms in rainbow trout peripheral blood lymphocytes: Role in PHA-induced lymphoproliferation. Dev Comp Immunol 1999;23:37-50.
33. Khan NA, Hichami A: Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem J 1999;344:199-204.
34. Mosmann T: Rapid colorimetric assay for cellular growth and survival application and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
35. Lima L, Walder R, Obregón F, Drujan B: Serotonin turnover rate in raphe and cortex of mice infected with Venezuelan equine encephalomyelitis virus. J Neurosci Res 1987;17:428-434.
36. Barker PJ, Taylor CE, Ekwunife FS: Bacterial polysaccharides, endotoxins, and immunomodulation. Adv Exp Med Biol 1992;319:31-38.
37. Li YS, Kouassi E, Revillard JP: Differential regulation of mouse B-cell activation by β-adrenoceptor stimulation depending on type of mitogens. Immunology 1990;69:367-372.
38. Van Wauwe JP, De Mey JR, Goossens JG: OKT3: A monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 1980;124:2708-2713.
39. Henkart P, Fisher R: Characterization of the lymphocyte surface receptors for Con A and PHA. J Immunol 1975;114(2 Pt 1):710-714.
40. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G, Francisco CA: Leptin-deficient (ob/ob) mice are protected from T-cell-mediated hepatotoxicity: Role of tumor necrosis factor-α and IL-18. Proc Natl Acad Sci USA 2000;97:2367-2372.
41. Fiorucci S, Santucci L, Antonelli E, Distrutt E, Del Sero G, Morelli O, Romani L, Federici B, Del Soldato P, Morelli A: NO-aspirin protects from T-cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology 2000;118:404-421.
42. Kurnick JT, Bell C, Grey HM: PHA-induced activation of suppressor cells in normal human peripheral blood lymphocytes. Scand J Immunol 1976;5:771-778.
43. Wang LL, McClain DA, Edelman GM: Modulation of lymphocyte mitogenesis. Proc Natl Acad Sci USA 1975;72:1917-1921.
44. Roberts D, Katz DR, Mukherjee S, Rook GA: Induction of delayed-type hypersensitivity responses to PPD: Dendritic cells in synergy with 5-hydroxytryptamine can substitute for macrophages. Immunology 1988;63:697-700.
45. Ayelli EV, Genaro AM, Cremaschi GA, Sterin BL: Fluoxetine action upon human T lymphocyte proliferation. Acta Physiol Pharmacol Ther Latinoam 1998;48:191-197.
46. 3 receptor channels coupled with Na+ influx in human T cells: Role in T cell activation. J Neuroimmunol 1999;99:53-60.
47. Hofman B, Afzelius P, Iversen J, Kronborg G, Aabech P, Benfield T, Dybkjaer E, Nielsen J: Buspirone, a serotonin receptor agonist, increases CD4+ T-cell counts and modulates the immune system in HIV-seropositive subjects. AIDS 1996;10:1339-1347.
48. McGregor DA, Prielipp RC, Butterworth JF, James RL, Royster RL: Relative efficacy and potency of β-adrenoceptor agonists for generating cAMP in human lymphocytes. Chest 1996;109:194-200.
49. Hadden JW, Hadden EM, Middleton E: Lymphocyte blast transformation. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1970;1:583-595.
50. Koff WC, Fann AV, Dunegan MA, Lachman LB: Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res 1986;5:239-247.
51. De Waal E, De Jong WH, Van del Vliet H, Verlaan B, Loveren HV: An immunotoxicity screening study on salmeterol in rats. Int J Immunopharmacol 1996;18:523-528.
52. Koh WS, Yang KH, Kaminshi NE: Cyclic AMP is an essential factor in immune responses. Biochem Biophys Res Commun 1995;206:703-709.
53. Aune T, Golden H, McGath M: Inhibitors of serotonin synthesis and antagonists of serotonin-1a receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 1994;153:489-498.
54. Koyuncuoglu P: The effects of DL-p- chlorophenylalanine and DL-α-methyl-p-tyrosine on the brain catecholamine, serotonin and free amino acid contents in rats. Psychopharmacology 1975;45:163-169.
55. Pellegrino TC, Bayer BM: Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation 2000;8:179-187.